Pulmonary Pleomorphic Carcinoma Mimicking Primary Sarcoma of the Neck: A Case Report and Literature Review

References

• Fishback NF, Travis WD, Moran CA, Guinee DG, McCarthy WF, Koss MN. Pleomorphic (spindle/giant cell) carcinoma of the lung. A clinicopathologic correlation of 78 cases. Cancer. 1994;73(12):2936–2945. doi:10.1002/1097-0142(19940615)73:12<2936::AID-CNCR2820731210>3.0.CO;2-U8199991
   PubMed Web of Science ®Google Scholar
• Travis WD, Brambilla E, Nicholson AG, et al. The 2015 World Health Organization classification of lung tumors: impact of genetic, clinical and radiologic advances since the 2004 classification. J Thorac Oncol. 2015;10(9):1243–1260. doi:10.1097/JTO.000000000000063026291008
   PubMed Web of Science ®Google Scholar
• Yendamuri S, Caty L, Pine M, et al. Outcomes of sarcomatoid carcinoma of the lung: a surveillance, epidemiology, and end results database analysis. Surgery. 2012;152(3):397–402. doi:10.1016/j.surg.2012.05.00722739072
   PubMed Web of Science ®Google Scholar
• Steuer CE, Behera M, Liu Y, et al. Pulmonary sarcomatoid carcinoma: an analysis of the national cancer data base. Clin Lung Cancer. 2017;18(3):286–292. doi:10.1016/j.cllc.2016.11.01628043773
   PubMed Web of Science ®Google Scholar
• Ito K, Oizumi S, Fukumoto S, et al. Clinical characteristics of pleomorphic carcinoma of the lung. Lung Cancer. 2010;68(2):204–210. doi:10.1016/j.lungcan.2009.06.00219577320
   PubMed Web of Science ®Google Scholar
• Rossi G, Cavazza A, Sturm N, et al. Pulmonary carcinomas with pleomorphic, sarcomatoid, or sarcomatous elements: a clinicopathologic and immunohistochemical study of 75 cases. Am J Surg Pathol. 2003;27(3):311–324. doi:10.1097/00000478-200303000-0000412604887
   PubMed Web of Science ®Google Scholar
• Huang SY, Shen SJ, Li XY. Pulmonary sarcomatoid carcinoma: a clinicopathologic study and prognostic analysis of 51 cases. World J Surg Oncol. 2013;11:252. doi:10.1186/1477-7819-11-25224088577
   PubMed Web of Science ®Google Scholar
• Tamura Y, Fujiwara Y, Yamamoto N, et al. Retrospective analysis of the efficacy of chemotherapy and molecular targeted therapy for advanced pulmonary pleomorphic carcinoma. BMC Res Notes. 2015;8:800. doi:10.1186/s13104-015-1762-z26682906
   PubMedGoogle Scholar
• Yuki T, Sakuma T, Onbayashi C, et al. Pleomorphic carcinoma of the lung: a surgical outcome. J Thorac Cardiovasc Surg. 2007;134(2):399–404. doi:10.1016/j.jtcvs.2007.04.01817662779
   PubMed Web of Science ®Google Scholar
• Koh H, Chiyotani A, Tokuda T, et al. Pleomorphic carcinoma showing rapid growth, multiple metastases, and intestinal perforation. Ann Thorac Cardiovasc Surg. 2014;20:669–673. doi:10.5761/atcs.cr.13-0016724492166
   PubMed Web of Science ®Google Scholar
• Chang YL, Lee YC, Shih JY, Wu CT. Pulmonary pleomorphic (spindle) cell carcinoma: peculiar clinicopathologic manifestations different from ordinary non-small cell carcinoma. Lung Cancer. 2001;34(1):91–97. doi:10.1016/S0169-5002(01)00224-011557118
   PubMed Web of Science ®Google Scholar
• Bae HM, Min HS, Lee SH, et al. Palliative chemotherapy for pleomorphic carcinoma. Lung Cancer. 2007;58(1):112–115. doi:10.1016/j.lungcan.2007.05.00617574296
   PubMed Web of Science ®Google Scholar
• Hong JY, Choi MK, Uhm JL, et al. The role of palliative chemotherapy for advanced pulmonary pleomorphic carcinoma. Med Oncol. 2009;26(3):287–291. doi:10.1007/s12032-008-9117-418989796
   PubMed Web of Science ®Google Scholar
• Sukrithan V, Sandler J, Gucalp R, Gralla R, Halmos B. Immune checkpoint blockade is associated with durable responses in pulmonary sarcomatoid carcinoma. Clin Lung Cancer. 2019;20(3):e242–e246. doi:10.1016/j.cllc.2018.12.01330665873
   PubMed Web of Science ®Google Scholar
• Senoo S, Ninomiya T, Makimoto G, et al. Rapid and long-term response of pulmonary pleomorphic carcinoma to nivolumab. Intern Med. 2019;58(7):985–989. doi:10.2169/internalmedicine.0890-1830568113
   PubMed Web of Science ®Google Scholar
• Chang HC, Hsu CL, Chang YL, Yu CJ. Pulmonary pleomorphic carcinoma with pembrolizumab monotherapy. Respirol Case Rep. 2020;8(6):e0597. doi:10.1002/rcr2.59732547767
   PubMed Web of Science ®Google Scholar
• Ota T, Niho S, Kirita K, Ishii G, Tsuboi M, Goto K. Impressive response to nivolumab of non-small-cell lung cancer containing sarcomatoid components. Respirol Case Rep. 2019;7(8):e00477.31452896
   PubMed Web of Science ®Google Scholar
• Tokuyasu H, Ishikawa S, Sakai H, Ikeuchi T, Miura H. Single pembrolizumab treatment causing profound durable response in a patient with pulmonary pleomorphic carcinoma. Respir Med Case Rep. 2019;28:100879. doi:10.1016/j.rmcr.2019.10087931249776
   PubMed Web of Science ®Google Scholar
• Basu A, Moreira AL, Simms A, Brandler TC. Sarcomatoid carcinoma in cytology: report of a rare entity presenting in pleural and pericardial fluid preparations. Diagn Cytopathol. 2019;47(8):813–816. doi:10.1002/dc.2418330908904
   PubMed Web of Science ®Google Scholar
• Kim MJ, Lee HN, Kim JI, Kim GY. Pleomorphic carcinoma of the lung mimicking synchronous pulmonary adenocarcinoma and small bowel sarcoma. Ann Thorac Med. 2018;13(4):251–253. doi:10.4103/atm.ATM_362_1730416598
   PubMed Web of Science ®Google Scholar
• Noguchi S, Kawachi H, Yoshida H, et al. Sarcoid-like granulomatosis induced by nivolumab treatment in a lung cancer patient. Case Rep Oncol. 2018;11(2):562–566. doi:10.1159/00049238330186140
   PubMed Web of Science ®Google Scholar
• Ando T, Goto Y, Mano K, et al. Paraneoplastic autoimmune encephalitis associated with pleomorphic lung carcinoma: an autopsy case report. Neuropathology. 2018;38(4):448–454. doi:10.1111/neup.12477
   Web of Science ®Google Scholar
• Masuda K, Tokito T, Azuma K, et al. Pulmonary pleomorphic carcinoma: a case harboring EGFR mutation treated with EGFR-TKIs. Thorac Cancer. 2018;9(6):754–757. doi:10.1111/1759-7714.1264629675860
   PubMed Web of Science ®Google Scholar
• Ustaoğlu M, Koçak G, Siviloğlu Ç, Cengiz E. An unusual case of duodenal metastasis of pulmonary pleomorphic carcinoma. Turk J Gastroenterol. 2018;29(1):136–137. doi:10.5152/tjg.2018.1728829391323
   PubMed Web of Science ®Google Scholar
• Okamura K, Fukuda Y, Soda H, et al. Pulmonary pleomorphic carcinoma with few PD-1-positive immune cells and regulatory T cells that showed a complete response to nivolumab. Thorac Cancer. 2018;9(1):193–196. doi:10.1111/1759-7714.1255729131510
   PubMed Web of Science ®Google Scholar
• Marchand L, Paulus V, Fabien N, et al. Nivolumab-induced acute diabetes mellitus and hypophysitis in a patient with advanced pulmonary pleomorphic carcinoma with a prolonged tumor response. J Thorac Oncol. 2017;12(11):e182–e184. doi:10.1016/j.jtho.2017.07.02129074210
   PubMedGoogle Scholar
• Matsumoto Y, Miura T, Horiuchi H, Usui K. The successful treatment of pulmonary pleomorphic carcinoma with pembrolizumab: a case report. Case Rep Oncol. 2017;10(2):752–757. doi:10.1159/00047955228878661
   PubMed Web of Science ®Google Scholar
• Arshad HS, Dudekula RA, Niazi M, Malik S, Khaja M. A rare case of sarcomatoid carcinoma of the lung with spine metastasis, including a literature review. Am J Case Rep. 2017;18:760–765. doi:10.12659/AJCR.90458428684728
   PubMed Web of Science ®Google Scholar
• Murai T, Yonetsu T, Isobe M, Kakuta T. Coronary embolization caused by pleomorphic lung carcinoma. Intern Med. 2016;55(24):3607–3609. doi:10.2169/internalmedicine.55.757127980261
   PubMed Web of Science ®Google Scholar
• Ito K, Hataji O, Katsuta K, Kobayashi T, Gabazza EC, Yatabe Y. “Pseudoprogression” of pulmonary pleomorphic carcinoma during nivolumab therapy. J Thorac Oncol. 2016;11(10):e117–e119. doi:10.1016/j.jtho.2016.05.00227189927
   PubMed Web of Science ®Google Scholar
• Oda T, Sekine A, Kato T, Baba T, Okudela K, Ogura T. Promising effect of chemotherapy with bevacizumab for patients with pulmonary pleomorphic carcinoma: two case reports and a literature review. Respir Investig. 2015;53(6):296–299. doi:10.1016/j.resinv.2015.05.004
   Google Scholar
• Murakami Y, Saka H, Oki M. Response to crizotinib and clinical outcome in ALK-rearranged pulmonary pleomorphic carcinoma. J Thorac Oncol. 2015;10(5):e28–e29. doi:10.1097/JTO.000000000000045025898961
   PubMed Web of Science ®Google Scholar
• Yamanashi K, Marumo S, Miura K, Kawashima M. Long-term survival in a case of pleomorphic carcinoma with a brain metastasis. Case Rep Oncol. 2014;7(3):799–803. doi:10.1159/00036818625566055
   PubMedGoogle Scholar
• Shimizu Y, Iguchi T, Nitta Y, Machida Y, Kuratsukuri K, Kawashima H. A case of pulmonary pleomorphic carcinoma with renal metastasis. Urol Case Rep. 2014;2(6):179–180. doi:10.1016/j.eucr.2014.07.00726958481
   PubMedGoogle Scholar
• Rice B, Ross J, Todd N, Caputo L, Rush S, Shrestha B. Pulmonary pleomorphic carcinoma metastasis to the midfoot. J Foot Ankle Surg. 2015;54(3):483–486. doi:10.1053/j.jfas.2014.04.01824840733
   PubMed Web of Science ®Google Scholar
• Lin MW, Wu CT, Chang YL. Intussusception caused by intestinal metastasis from lung pleomorphic carcinoma. Ann Thorac Cardiovasc Surg. 2014;20:635–638. doi:10.5761/atcs.cr.13-0009923903709
   PubMed Web of Science ®Google Scholar
• Ioncica AM, Atiq M, Lee JH, Saftoiu A, Bhutani MS. Gastric and pancreatic metastases from pleomorphic lung carcinoma. Endoscopy. 2011;43:UCTN:E317-E318. doi:10.1055/s-0030-1256686
   Web of Science ®Google Scholar
• Rashid S, Rajan D, Jacob R, et al. Colonic metastases from pleomorphic carcinoma of the lung presenting as an ileocecal intussusception. ISRN Gastroenterol. 2011;2011:137139. doi:10.5402/2011/13713921991496
   PubMedGoogle Scholar
• Saitoh M, Niijima M, Takiguchi Y, et al. An early event of EGFR mutation in pleomorphic carcinoma of the lung. Int J Clin Oncol. 2011;16(6):770–773. doi:10.1007/s10147-011-0247-x21556797
   PubMed Web of Science ®Google Scholar
• Lee KW, Kim YJ, Kim JH, Bang SM, Chung JH, Lee JS. Two consecutive cases of platinum-refractory pulmonary pleomorphic carcinoma that showed dramatic responses to MAID (mesna, doxorubicin, ifosfamide and dacarbazine) chemotherapy. Jpn J Clin Oncol. 2011;41(3):430–433. doi:10.1093/jjco/hyq18020926411
   PubMed Web of Science ®Google Scholar
• Shi B, Gaebelein G, Hildebrandt B, Weichert W, Glanemann M. Adult jejunojejunal intussusception caused by metastasized pleomorphic carcinoma of the lung: report of a case. Surg Today. 2009;39(11):984–989. doi:10.1007/s00595-008-3954-919882322
   PubMed Web of Science ®Google Scholar
• Nomura R, Yoshida D, Kim K, Kobayashi S, Teramoto A. Intracerebral hemorrhage caused by a neoplastic aneurysm from pleomorphic lung carcinoma. Neurol Med Chir (Tokyo). 2009;49(1):33–36. doi:10.2176/nmc.49.3319169001
   PubMed Web of Science ®Google Scholar
• Ushiki A, Koizumi T, Kobayashi N, et al. Genetic heterogeneity of EGFR mutation in pleomorphic carcinoma of the lung: response to gefitinib and clinical outcome. Jpn J Clin Oncol. 2009;39(4):267–270. doi:10.1093/jjco/hyn15519155283
   PubMed Web of Science ®Google Scholar
• Aokage K, Yoshida J, Ishii G, et al. Long-term survival in two cases of resected gastric metastasis of pulmonary pleomorphic carcinoma. J Thorac Oncol. 2008;3(7):796–799. doi:10.1097/JTO.0b013e31817c925c18594328
   PubMed Web of Science ®Google Scholar
• Yilmaz A, Sulu E, Arinç S, et al. Pleomorphic carcinoma of the lung: a report of six cases. Tuberk Toraks. 2007;55(3):290–294.17978928
   PubMedGoogle Scholar
• Burnette RE, Ballard BR. Metastatic pleomorphic carcinoma of lung presenting as abdominal pain. J Natl Med Assoc. 2004;96(12):1657–1660.15622698
   PubMed Web of Science ®Google Scholar
• Fujisaki A, Aoki T, Kasai T, et al. Pleomorphic carcinoma of the lung: relationship between CT findings and prognosis. AJR Am J Roentgenol. 2016;207(2):289–294. doi:10.2214/AJR.15.1554227144416
   PubMed Web of Science ®Google Scholar
• Pezzuto A, Citarella F, Croghan I, Tonini G. The effects of cigarette smoking extracts on cell cycle and tumor spread: novel evidence. Future Sci OA. 2019;5(5):FSO394. doi:10.2144/fsoa-2019-001731205749
   PubMed Web of Science ®Google Scholar
• Pezzuto A, Carico E. Role of HIF-1 in cancer progression: novel insights. Curr Mol Med. 2018;18(6):343–351. doi:10.2174/156652401866618110912184930411685
   PubMed Web of Science ®Google Scholar
• Lee J, Choi Y, Jung HA, et al. Outstanding clinical efficacy of PD-1/PD-L1 inhibitors for pulmonary pleomorphic carcinoma. Eur J Cancer. 2020;132:150–158. doi:10.1016/j.ejca.2020.03.02932371248
   PubMed Web of Science ®Google Scholar
• Ancoš V, Farkašová A, Kviatkovská Z, et al. Non-small cell lung carcinomas with a minor sarcomatoid component and pleomorphic carcinomas are associated with high expression of programmed death ligand 1. Pathol Res Pract. 2020;216(12):153238. doi:10.1016/j.prp.2020.15323833059241
   PubMed Web of Science ®Google Scholar